Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease

Su, Y; Jennings, NL; Lambert, G; Pang, T; Du, XJ; Head, GA; La Greca, L; Du, X; Hannan, AJ; Davern, P; Kiriazis, H
Abstract
Huntington's disease (HD) is a heritable neurodegenerative disorder, with heart disease implicated as one major cause of death. While the responsible mechanism remains unknown, autonomic nervous system (ANS) dysfunction may play a role. We studied the cardiac phenotype in R6/1 transgenic mice at early (3 months old) and advanced (7 months old) stages of HD. While exhibiting a modest reduction in cardiomyocyte diameter, R6/1 mice had preserved baseline cardiac function. Conscious ECG telemetry revealed the absence of 24-h variation of heart rate (HR), and higher HR levels than wild-type littermates in young but not older R6/1 mice. Older R6/1 mice had increased plasma level of noradrenaline (NA), which was associated with reduced cardiac NA content. R6/1 mice also had unstable R-R intervals that were reversed following atropine treatment, suggesting parasympathetic nervous activation, and developed brady- and tachyarrhythmias, including paroxysmal atrial fibrillation and sudden death. c-Fos immunohistochemistry revealed greater numbers of active neurons in ANS-regulatory regions of R6/1 brains. Collectively, R6/1 mice exhibit profound ANS-cardiac dysfunction involving both sympathetic and parasympathetic limbs, that may be related to altered central autonomic pathways and lead to cardiac arrhythmias and sudden death.
Journal J PHYSIOL
ISSN 0022-3751
Published 15 Nov 2012
Volume 590
Issue Pt 22
Pages 5845-60
DOI 10.1113/jphysiol.2012.238113
Type Journal Article
Sponsorship
NHMRC: 1012881, 418902, 1002186, 317808